Imunon, Inc.
IMNNNasdaqCIK 749647HealthcareFiscal year ends Dec 31
Reports and events: 392 filings
Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.
What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.
| Filed | Form | What it is | Accession number |
|---|---|---|---|
| 2026-10-2706:15 ET | S-1 | Registration statement | 0001493152-26-048630 |
| 2026-10-2706:05 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001493152-26-048625 |
| 2026-10-2108:15 ET | 8-K | 1.01 Entry into a material agreement; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001493152-26-047850 |
| 2026-09-2908:00 ET | 8-K | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 5.03 Amendment to articles or bylaws; 9.01 Financial statements and exhibits | 0001493152-26-044792 |
| 2026-08-1117:00 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001493152-26-037170 |
| 2026-08-1108:30 ET | 10-Q | Quarterly reportPeriod 2026-06-30 | 0001493152-26-036991 |
| 2026-08-1108:01 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001493152-26-036985 |
| 2026-06-3016:30 ET | 8-K | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001493152-26-031292 |
| 2026-06-1617:30 ET | 8-K | 5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001493152-26-028937 |
| 2026-06-0408:00 ET | 8-K | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 3.02 Unregistered sale of equity; 5.03 Amendment to articles or bylaws; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001493152-26-027201 |
| 2026-05-1208:45 ET | 10-Q | Quarterly reportPeriod 2026-03-31 | 0001493152-26-022416 |
| 2026-05-1208:05 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001493152-26-022401 |
| 2026-05-0408:00 ET | 8-K | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001493152-26-021019 |
| 2026-05-0406:31 ET | DEF 14A | Proxy statementPeriod 2026-05-04 | 0001493152-26-020999 |
| 2026-03-3108:50 ET | 10-K | Annual reportPeriod 2025-12-31 | 0001493152-26-013850 |
| 2026-03-3108:05 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001493152-26-013816 |
| 2026-03-2316:16 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001493152-26-012164 |
| 2026-02-0508:05 ET | 8-K | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001493152-26-005203 |
| 2026-01-0717:15 ET | 8-K | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001493152-26-000841 |
| 2025-12-3108:00 ET | 8-K | 1.01 Entry into a material agreement; 8.01 Other events; 9.01 Financial statements and exhibits | 0001493152-25-029711 |
| 2025-11-1307:55 ET | 10-Q | Quarterly reportPeriod 2025-09-30 | 0001493152-25-022120 |
| 2025-11-1307:48 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001493152-25-022118 |
| 2025-08-2808:08 ET | 8-K | 3.01 Delisting notice; 9.01 Financial statements and exhibits | 0001493152-25-012417 |
| 2025-08-0509:00 ET | 10-Q | Quarterly reportPeriod 2025-06-30 | 0001493152-25-011598 |
| 2025-08-0508:03 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001493152-25-011597 |
| 2025-07-2808:10 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001493152-25-011440 |
| 2025-07-2308:02 ET | 8-K | 3.03 Change to security holders’ rights; 5.03 Amendment to articles or bylaws; 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001641172-25-020652 |
| 2025-07-2208:05 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001641172-25-020520 |
| 2025-07-1417:12 ET | 8-K | 3.01 Delisting notice; 5.02 Departure or appointment of officers or directors | 0001641172-25-019541 |
| 2025-07-1117:00 ET | 8-K | 3.03 Change to security holders’ rights; 5.03 Amendment to articles or bylaws; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001641172-25-018797 |
| 2025-06-1317:15 ET | 8-K | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001641172-25-015124 |
| 2025-06-0916:30 ET | DEF 14A | Proxy statementPeriod 2025-06-09 | 0001641172-25-014324 |
| 2025-06-0914:35 ET | 8-K | 8.01 Other events | 0001641172-25-014279 |
| 2025-05-3017:03 ET | S-1 | Registration statement | 0001641172-25-013088 |
| 2025-05-3016:30 ET | 8-K | 3.01 Delisting notice | 0001641172-25-013051 |
| 2025-05-2707:30 ET | 8-K | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 8.01 Other events; 9.01 Financial statements and exhibits | 0001641172-25-012395 |
| 2025-05-2209:27 ET | 8-K | 8.01 Other events | 0001641172-25-011999 |
| 2025-05-2007:00 ET | 8-K | 3.01 Delisting notice | 0001641172-25-011601 |
| 2025-05-1908:20 ET | S-1/A | Registration statement, amended | 0001641172-25-011388 |
| 2025-05-1306:10 ET | S-1/A | Registration statement, amended | 0001641172-25-009814 |
| 2025-05-1319:29 ET | 8-K | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 9.01 Financial statements and exhibits | 0001641172-25-009775 |
| 2025-05-1208:15 ET | 10-Q | Quarterly reportPeriod 2025-03-31 | 0001641172-25-009572 |
| 2025-05-1208:05 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001641172-25-009570 |
| 2025-04-0417:29 ET | S-1 | Registration statement | 0001641172-25-002783 |
| 2025-03-2408:05 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001641172-25-000207 |
| 2025-02-2708:15 ET | 10-K | Annual reportPeriod 2024-12-31 | 0001493152-25-008460 |
| 2025-02-2708:10 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001493152-25-008457 |
| 2025-02-1008:10 ET | 8-K | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001493152-25-005536 |
| 2024-11-2716:30 ET | 8-K | 3.01 Delisting notice | 0001493152-24-048008 |
| 2024-11-0709:05 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001493152-24-043933 |
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 27, 2026, 16:17 ET. Listed shows no prices and gives no investment advice.